Setback to Natco pharma; US Supreme Court sends Teva patent case to Federal Circuit

The US Supreme Court has sent back the patent case related to Teva's multiple sclerosis drug Copaxone for a review by the Federal Circuit.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news